FIST ASSIST EXECUTIVE SUMMARY - final
The executive summary presents Fist Assist Devices LLC, a Silicon Valley medical‑device startup founded by Dr. Tej M. Singh, MD, MBA, that is developing the first wearable, battery‑operated intermittent‑compression device to dilate arm veins and improve arteriovenous (AV) fistula maturation for end‑stage renal disease (ESRD) patients. The company’s vision is to create a low‑cost, non‑invasive home wearable that enhances vein preparation, reduces catheter time, shortens fistula maturation, and lowers overall ESRD treatment costs. The problem is framed by the high financial burden of ESRD (≈$34 billion annually), poor fistula outcomes, and limited patient‑controlled options (upper‑arm rubber band, squeeze ball) that suffer from low compliance. The patented device (US 8231558 B2, protection through July 2032) uses external pneumatic compression to enlarge veins. Market opportunity is underscored by the prevalence of chronic kidney disease (≈40 million US adults) and projected dialysis patients (≈4.9 million worldwide by 2025). Competitive advantage lies in offering a simple, wearable solution versus existing exercise‑based methods. The business model includes direct device sales worldwide and a subscription‑based vascular‑access education service. The team combines over 80 years of med‑device experience, led by a vascular‑access surgeon with 20 years of research. The company seeks $500 K–$1 M in working capital to scale manufacturing, marketing, and team expansion toward profitability.
Topics
Vision & Mission: Non‑invasive Wearable for Vein Enhancement in ESRD
Defines the company’s long‑term goal to create a low‑cost, home‑wearable that dilates veins and improves the patient journey through end‑stage renal disease.
Problem Landscape: High Costs and Poor Outcomes in AV Fistula Maturation
Outlines the clinical and economic challenges—high ESRD expenditures, low fistula maturation rates, and limited patient‑controlled options—supporting the need for a new solution.
Device Innovation: Intermittent Compression Wearable with Patent US 8231558 B2
Describes the patented, battery‑operated external pneumatic compression device, its minimal viable product visuals, and its protection through July 2032.
Market Opportunity: ESRD Burden and Growth Projections
Presents key market statistics—ESRD accounts for 6% of Medicare budget, $34 billion annual cost, 40 million US adults with CKD, 3.6 million worldwide ESRD patients, projected 4.9 million dialysis patients by 2025—highlighting a sizable addressable market.
Competitive Landscape: Limitations of Upper‑Arm Band and Squeeze Ball
Compares existing patient‑controlled methods (rubber band, squeeze ball) that rely on repetitive movements and suffer from poor compliance, establishing the unmet need.